proZane Competitors

Aireco Supply, Inc. (Aireco), founded in 1952, is a major regional heating, air conditioning and refrigeration wholesaler operating in the Maryland, Virginia, Delaware and Washington, D.C. markets. Today Aireco has 44 branch locations, conveniently located throughout the Metro Baltimore/Washington/Virginia area. With 250 product lines, 20,000 items, knowledgeable sales personnel, extensive customer training and much more, Aireco is committed to being a full service HVAC/R supplier to their valued customers.

For over 35 years, Fresh Air Corp has been providing the very finest duct cleaning services to the residential and commercial markets of Central Ohio. We’re committed to offering our customers not only the most thorough cleaning possible, but absolute honesty in the way we price our service. No phony coupons, no bait & switch scams and no fraudulent mold testing – just the following commitment : To treat you with honesty and integrity To give you more than your money’s worth To be punctual and keep you informed of any problems To protect your property and home as if it were our own Check us out on the Better Business Bureau or ask your heating and cooling contractor who they would recommend. At Fresh Air Corp, you’ll be given a firm quote right on the phone and receive only the most professional service possible.

GlycoTech has maintained a corporate alliance with Novartis for the past six years to develop small molecule mimics of carbohydrate ligands as potent antagonists for the aberrant extravasation of lymphocytes from the bloodstream during transplantation-induced reperfusion injury. In addition, licensing agreements were recently established with Chiron Corporation for worldwide sales in cancer diagnostics using anti-carbohydrate tumor markers owned by GlycoTech. Research agreements have also been established with the National Institutes of Health, the University of Pennsylvania, the University of Rochester, and the Chicago Institute for Neurosurgery and Neuroresearch. GlycoTech is actively seeking other pharmaceutical partners and offers a combined range of expertise focusing on the Glycobiology area. The corporate structure and strategy of GlycoTech allows its partners to quickly obtain this unique expertise and avoid the obligations encountered with the fixed financial responsibilities associated with internal organic growth. We welcome the opportunity to meet with all interested parties to explore mutually constructive collaborations.